Caseware UK (AP4) 2025.0.111 2025.0.111 2025-12-312025-12-312025-12-31false0No description of principal activity2025-01-010falsefalsefalse 15183412 2025-01-01 2025-12-31 15183412 2023-10-03 2024-12-31 15183412 2025-12-31 15183412 2024-12-31 15183412 c:CompanySecretary1 2025-01-01 2025-12-31 15183412 c:Director1 2025-01-01 2025-12-31 15183412 c:RegisteredOffice 2025-01-01 2025-12-31 15183412 d:Buildings 2025-01-01 2025-12-31 15183412 d:PlantMachinery 2025-01-01 2025-12-31 15183412 d:MotorVehicles 2025-01-01 2025-12-31 15183412 d:FurnitureFittings 2025-01-01 2025-12-31 15183412 d:OfficeEquipment 2025-01-01 2025-12-31 15183412 d:ComputerEquipment 2025-01-01 2025-12-31 15183412 d:Goodwill 2025-01-01 2025-12-31 15183412 d:CurrentFinancialInstruments 2025-12-31 15183412 d:CurrentFinancialInstruments 2024-12-31 15183412 d:Non-currentFinancialInstruments 2025-12-31 15183412 d:Non-currentFinancialInstruments 2024-12-31 15183412 d:CurrentFinancialInstruments d:WithinOneYear 2025-12-31 15183412 d:CurrentFinancialInstruments d:WithinOneYear 2024-12-31 15183412 d:Non-currentFinancialInstruments d:AfterOneYear 2025-12-31 15183412 d:Non-currentFinancialInstruments d:AfterOneYear 2024-12-31 15183412 d:Non-currentFinancialInstruments d:BetweenOneTwoYears 2025-12-31 15183412 d:Non-currentFinancialInstruments d:BetweenOneTwoYears 2024-12-31 15183412 d:Non-currentFinancialInstruments d:BetweenTwoFiveYears 2025-12-31 15183412 d:Non-currentFinancialInstruments d:BetweenTwoFiveYears 2024-12-31 15183412 d:Non-currentFinancialInstruments d:MoreThanFiveYears 2025-12-31 15183412 d:Non-currentFinancialInstruments d:MoreThanFiveYears 2024-12-31 15183412 d:ShareCapital 2025-01-01 2025-12-31 15183412 d:ShareCapital 2025-12-31 15183412 d:ShareCapital 2023-10-03 2024-12-31 15183412 d:ShareCapital 2024-12-31 15183412 d:RetainedEarningsAccumulatedLosses 2025-01-01 2025-12-31 15183412 d:RetainedEarningsAccumulatedLosses 2025-12-31 15183412 d:RetainedEarningsAccumulatedLosses 2023-10-03 2024-12-31 15183412 d:RetainedEarningsAccumulatedLosses 2024-12-31 15183412 d:RetainedEarningsAccumulatedLosses 2023-10-03 15183412 c:OrdinaryShareClass1 2025-01-01 2025-12-31 15183412 c:OrdinaryShareClass1 2025-12-31 15183412 c:OrdinaryShareClass1 2024-12-31 15183412 c:FRS102 2025-01-01 2025-12-31 15183412 c:Audited 2025-01-01 2025-12-31 15183412 c:FullAccounts 2025-01-01 2025-12-31 15183412 c:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 15183412 d:Subsidiary1 2025-01-01 2025-12-31 15183412 d:Subsidiary1 1 2025-01-01 2025-12-31 15183412 c:Consolidated 2025-12-31 15183412 c:ConsolidatedGroupCompanyAccounts 2025-01-01 2025-12-31 15183412 2 2025-01-01 2025-12-31 15183412 6 2025-01-01 2025-12-31 15183412 15 2025-01-01 2025-12-31 15183412 17 2025-01-01 2025-12-31 15183412 18 2025-01-01 2025-12-31 15183412 19 2025-01-01 2025-12-31 15183412 20 2025-01-01 2025-12-31 15183412 e:PoundSterling 2025-01-01 2025-12-31 xbrli:shares iso4217:GBP xbrli:pure
Registered number: 15183412


KONKU CARE (SUTTON) LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2025




 
KONKU CARE (SUTTON) LIMITED
 
 
COMPANY INFORMATION


Director
S K Konkumalla 




Company secretary
B Konkumalla



Registered number
15183412



Registered office
Orchard House
35 Hallmead Road

Sutton

Surrey

SM1 1RD





 
KONKU CARE (SUTTON) LIMITED
 

CONTENTS



Page
Group strategic report
1 - 2
Director's report
3 - 4
Independent auditors' report
5 - 9
Consolidated statement of comprehensive income
10
Consolidated balance sheet
11 - 12
Company balance sheet
13 - 14
Consolidated statement of changes in equity
15 - 16
Company statement of changes in equity
17 - 18
Consolidated statement of cash flows
19 - 20
Consolidated analysis of net debt
21
Notes to the financial statements
22 - 44


 
KONKU CARE (SUTTON) LIMITED
 
 
GROUP STRATEGIC REPORT
FOR THE PERIOD ENDED 31 DECEMBER 2025

Introduction
 
The director presents his strategic report on the accounts for the year ended 31 December 2025.

Business review
 
The group's principal activity continues to be the operation of  nursing homes based in Surrey.

On 15 October 2025, the company purchased another nursing home in the Surrey area.

Principal risks and uncertainties
 
The principal risk to the growth in fees generated in the companies is that local authorities and the NHS do not increase their payments at the same rate as the rise in cost of operating the care homes. Experience shows, however, that supply and demand over the long-term help to adjust this difference.

Historically, staff costs account for typically 65% to 70% of the total operation costs in a care home. Any government pay rises to NHS nursing staff need to be matched for those working in the care home in order to retain staff.

The lower paid staff wage rates are linked directly to the level of the minimum wage. Any percentage increases in the minimum wage above the percentage rate of increase in the fees agreed by local goverment to be paid to care homes impacts on the group's profitability.

The director ensures that there are agreements in place with the local authorities, together with regular dialogue, to ensure occupancy rates are maintained at a high level.

The director recognises the importance of staff and in particular nursing staff. Staff is the company's greatest asset. For this reason the director dedicates time and resources to ensuring the permanent recruitment of nursing staff instead of being reliant on agency staff, who are only used as a last resort. This ensures continuity with quality of care.

Financial key performance indicators
 
The group's key performance indication is the monthly turnover. The results for the year showed turnover amounting to £4,424,407,(9 months to 31 December 2024 - £3,192,098). The major reason for better performance compared to the group performance prior to acquisition was the continued higher bed occupancy as a result of more shared rooms during the financial period which results in a greater turnover.

The group's other key performance indicator is the monthly staff costs. As noted above the total costs are typically 65% to 70% of fee income. For 31 December 2025 this amounted to 64.13% (2024 - 61.95%) and was the result of the high occupancy level achieved referred to above.

Other key performance indicators
 
The company's key performance indication is the weekly occupancy report. The group has managed to maintain occupancy rates of at least 95%, which in turn enables the delivery of the care noted above using permanent staff.

Page 1

 
KONKU CARE (SUTTON) LIMITED
 

GROUP STRATEGIC REPORT (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2025


This report was approved by the board on 21 September 2026 and signed on its behalf.








S K Konkumalla
Director

Page 2

 
KONKU CARE (SUTTON) LIMITED
 
 
 
DIRECTOR'S REPORT
FOR THE PERIOD ENDED 31 DECEMBER 2025

The director presents his report and the financial statements for the period ended 31 December 2025.

Director's responsibilities statement

The director is responsible for preparing the Group strategic report, the Director's report and the consolidated financial statements in accordance with applicable law and regulations.
 
Company law requires the director to prepare financial statements for each financial year. Under that law the director has elected to prepare the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), including Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland'. Under company law the director must not approve the financial statements unless he is satisfied that they give a true and fair view of the state of affairs of the Company and the Group and of the profit or loss of the Group for that period.

 In preparing these financial statements, the director is required to:


∙select suitable accounting policies for the Group's financial statements and then apply them consistently;

∙make judgments and accounting estimates that are reasonable and prudent;

∙prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Group will continue in business.

The director is responsible for keeping adequate accounting records that are sufficient to show and explain the Company's transactions and disclose with reasonable accuracy at any time the financial position of the Company and the Group and to enable him to ensure that the financial statements comply with the Companies Act 2006. He is also responsible for safeguarding the assets of the Company and the Group and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Results and dividends

The profit for the period, after taxation, amounted to £298,284 (2024 - £146,542).

No dividends have been proposed for the period.

Director

The director who served during the period was:

S K Konkumalla 

Disclosure of information to auditors

The director at the time when this Director's report is approved has confirmed that:
 
∙so far as he is aware, there is no relevant audit information of which the Company and the Group's auditors are unaware, and

∙he has taken all the steps that ought to have been taken as a director in order to be aware of any relevant audit information and to establish that the Company and the Group's auditors are aware of that information.

Page 3

 
KONKU CARE (SUTTON) LIMITED
 
 
 
DIRECTOR'S REPORT (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2025

Auditors

The auditors, CWM, will be proposed for reappointment in accordance with section 485 of the Companies Act 2006.

This report was approved by the board on 21 September 2026 and signed on its behalf.
 








S K Konkumalla
Director

Page 4

 
KONKU CARE (SUTTON) LIMITED
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF KONKU CARE (SUTTON) LIMITED
 

Opinion


We have audited the financial statements of KONKU CARE (SUTTON) LIMITED (the 'Parent Company') and its subsidiaries (the 'Group') for the period ended 31 December 2025, which comprise the Consolidated statement of comprehensive income, the Consolidated analysis of net debt, the Consolidated balance sheet, the Company balance sheet, the Consolidated statement of cash flows, the Consolidated statement of changes in equity, the Company statement of changes in equity and the related notes, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).


In our opinion the financial statements:


∙give a true and fair view of the state of the Group's and of the Parent Company's affairs as at 31 December 2025 and of the Group's profit for the period then ended;
∙have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
∙have been prepared in accordance with the requirements of the Companies Act 2006.


Basis for opinion


We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the Group in accordance with the ethical requirements that are relevant to our audit of the financial statements in the United Kingdom, including the Financial Reporting Council's Ethical Standard and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.


Conclusions relating to going concern


In auditing the financial statements, we have concluded that the director's use of the going concern basis of accounting in the preparation of the financial statements is appropriate.


Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Group's or the Parent Company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.


Our responsibilities and the responsibilities of the director with respect to going concern are described in the relevant sections of this report.


Page 5

 
KONKU CARE (SUTTON) LIMITED
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF KONKU CARE (SUTTON) LIMITED (CONTINUED)


Other information


The other information comprises the information included in the Annual Report other than the financial statements and our Auditors' report thereon. The director is responsible for the other information contained within the Annual Report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.


We have nothing to report in this regard.


Opinion on other matters prescribed by the Companies Act 2006
 

In our opinion, based on the work undertaken in the course of the audit:


∙the information given in the Group strategic report and the Director's report for the financial period for which the financial statements are prepared is consistent with the financial statements; and
∙the Group strategic report and the Director's report have been prepared in accordance with applicable legal requirements.


Matters on which we are required to report by exception
 

In the light of the knowledge and understanding of the Group and the Parent Company and its environment obtained in the course of the audit, we have not identified material misstatements in the Group strategic report or the Director's report.


We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:


∙adequate accounting records have not been kept by the Parent Company, or returns adequate for our audit have not been received from branches not visited by us; or
∙the Parent Company financial statements are not in agreement with the accounting records and returns; or
∙certain disclosures of director's remuneration specified by law are not made; or
∙we have not received all the information and explanations we require for our audit.


Page 6

 
KONKU CARE (SUTTON) LIMITED
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF KONKU CARE (SUTTON) LIMITED (CONTINUED)


Responsibilities of directors
 

As explained more fully in the Director's responsibilities statement set out on page 3, the director is responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the director determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.


In preparing the financial statements, the director is responsible for assessing the Group's and the Parent Company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the director either intends to liquidate the Group or the Parent Company or to cease operations, or has no realistic alternative but to do so.


Page 7

 
KONKU CARE (SUTTON) LIMITED
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF KONKU CARE (SUTTON) LIMITED (CONTINUED)


Auditors' responsibilities for the audit of the financial statements
 

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an Auditors' report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these Group financial statements.


Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

As part of designing our audit approach, we determined a materiality level and assessed the risks of material misstatement in the financial statements, including how fraud may occur through enquiries of management regarding its assessment of the areas and liklihood of fraud.

We looked at the areas where subjective judgements were made by management. In particular we looked at significant accounting estimates which were the result of assumptions made and based upon future events which are inherently uncertain. We also considered the effect of potential financial and other pressures, opportunity and motivations for fraud. We identified the use of internal controls established to mitigate risks related to fraud or non-compliance with laws and regulations and how management motitor these procedures. As part of our audit we reviewed and tested journals, key estimates and judgements made by management.

Our tests included agreeing the financial statements disclosures to underlying supporting documentation and enquiries with management.

We did not identify any key audit matters relating to irregularites, including fraud. We considered the risk of management override of internal controls and carried out tests to to evaluate this.

Our audit procedures are designed to identify risks of material misstatement, recognising that risks of not detecting such material misstatements due to fraud is greater then the risk due to error, due to the fact that fraud may well involve deliberate concealment. The audit procedures have inherent limitations. The further removed that non-compliance with laws and regulations are from the events and transactions included in the financial statements, the less likely we are to detect it.


A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our Auditors' report.


Page 8

 
KONKU CARE (SUTTON) LIMITED
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF KONKU CARE (SUTTON) LIMITED (CONTINUED)


Use of our report
 

This report is made solely to the Company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the Company's members those matters we are required to state to them in an Auditors' report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company and the Company's members, as a body, for our audit work, for this report, or for the opinions we have formed.








Mark Cooper FCA (Senior statutory auditor)
  
for and on behalf of
CWM
 
Chartered Accountants
Registered Auditors
  
1a High Street
Epsom
Surrey
KT19 8DA

21 September 2026
Page 9

 
KONKU CARE (SUTTON) LIMITED
 
 
CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
FOR THE PERIOD ENDED 31 DECEMBER 2025

31 December
Period ended
31 December
2025
2024
Note
£
£

  

Turnover
 4 
5,147,946
3,192,098

Cost of sales
  
(2,918,542)
(1,834,606)

Gross profit
  
2,229,404
1,357,492

Administrative expenses
  
(1,443,851)
(883,314)

Other operating income
 5 
10,353
-

Operating profit
 6 
795,906
474,178

Interest receivable and similar income
 10 
51,482
14

Interest payable and similar expenses
 11 
(357,469)
(143,978)

Profit before taxation
  
489,919
330,214

Tax on profit
 12 
(191,635)
(183,672)

Profit for the financial period
  
298,284
146,542

  

Total comprehensive income for the period
  
298,284
146,542

Profit for the period attributable to:
  

Owners of the Parent Company
  
298,284
146,542

  
298,284
146,542

Total comprehensive income for the period attributable to:
  

Owners of the Parent Company
  
298,284
146,542

  
298,284
146,542

The notes on pages 22 to 44 form part of these financial statements.

Page 10

 
KONKU CARE (SUTTON) LIMITED
REGISTERED NUMBER: 15183412

CONSOLIDATED BALANCE SHEET
AS AT 31 DECEMBER 2025

2025
2024
Note
£
£

Fixed assets
  

Intangible assets
 13 
4,969,751
1,421,404

Tangible assets
 14 
10,296,418
5,118,330

  
15,266,169
6,539,734

Current assets
  

Debtors: amounts falling due within one year
 16 
3,549,524
340,286

Cash at bank and in hand
 17 
590,939
175,455

  
4,140,463
515,741

Creditors: amounts falling due within one year
 18 
(5,392,801)
(4,182,799)

Net current liabilities
  
 
 
(1,252,338)
 
 
(3,667,059)

Total assets less current liabilities
  
14,013,831
2,872,675

Creditors: amounts falling due after more than one year
 19 
(13,081,744)
(2,403,906)

Provisions for liabilities
  

Deferred taxation
 21 
(235,986)
(70,952)

  
 
 
(235,986)
 
 
(70,952)

Net assets excluding pension asset
  
696,101
397,817

Net assets
  
696,101
397,817


Capital and reserves
  

Called up share capital 
 22 
100
100

Profit and loss account
  
696,001
397,717

Equity attributable to owners of the Parent Company
  
696,101
397,817

  
696,101
397,817


Page 11

 
KONKU CARE (SUTTON) LIMITED
REGISTERED NUMBER: 15183412
    
CONSOLIDATED BALANCE SHEET (CONTINUED)
AS AT 31 DECEMBER 2025

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 21 September 2026.







S K Konkumalla
Director

The notes on pages 22 to 44 form part of these financial statements.

Page 12

 
KONKU CARE (SUTTON) LIMITED
REGISTERED NUMBER: 15183412

COMPANY BALANCE SHEET
AS AT 31 DECEMBER 2025

2025
2024
Note
£
£

Fixed assets
  

Investments
 15 
12,823,617
4,225,000

  
12,823,617
4,225,000

Current assets
  

Debtors: amounts falling due within one year
 16 
5,121,071
2,376,769

Cash at bank and in hand
 17 
3,599
10,375

  
5,124,670
2,387,144

Creditors: amounts falling due within one year
 18 
(4,895,471)
(4,207,636)

Net current assets/(liabilities)
  
 
 
229,199
 
 
(1,820,492)

Total assets less current liabilities
  
13,052,816
2,404,508

  

Creditors: amounts falling due after more than one year
 19 
(13,081,744)
(2,403,906)

  

Net assets excluding pension asset
  
(28,928)
602

Net (liabilities)/assets
  
(28,928)
602


Capital and reserves
  

Called up share capital 
 22 
100
100

Profit and loss account brought forward
  
502
-

Loss/(profit) for the period
  
(29,530)
502

Profit and loss account carried forward
  
(29,028)
502

  
(28,928)
602


The financial statements were approved and authorised for issue by the board and were signed on its behalf on 21 September 2026.







S K Konkumalla
Director

The notes on pages 22 to 44 form part of these financial statements.
Page 13

 
KONKU CARE (SUTTON) LIMITED
REGISTERED NUMBER: 15183412
    
COMPANY BALANCE SHEET (CONTINUED)
AS AT 31 DECEMBER 2025


Page 14

 
KONKU CARE (SUTTON) LIMITED
 

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
FOR THE PERIOD ENDED 31 DECEMBER 2025


Called up share capital
Profit and loss account
Equity attributable to owners of Parent Company
Total equity

£
£
£
£

At 1 January 2025
100
397,717
397,817
397,817


Comprehensive income for the period

Profit for the period

-
298,284
298,284
298,284


Other comprehensive income for the period
-
-
-
-


Total comprehensive income for the period
-
298,284
298,284
298,284


Total transactions with owners
-
-
-
-


At 31 December 2025
100
696,001
696,101
696,101


The notes on pages 22 to 44 form part of these financial statements.

Page 15

 
KONKU CARE (SUTTON) LIMITED
 

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
FOR THE PERIOD ENDED 31 DECEMBER 2024


Called up share capital
Profit and loss account
Equity attributable to owners of Parent Company
Total equity

£
£
£
£


Comprehensive income for the period

Profit for the period

-
146,542
146,542
146,542

Fair value adjustments
-
251,175
251,175
251,175


Other comprehensive income for the period
-
251,175
251,175
251,175


Total comprehensive income for the period
-
397,717
397,717
397,717


Contributions by and distributions to owners

Shares issued during the period
100
-
100
100


Total transactions with owners
100
-
100
100


At 31 December 2024
100
397,717
397,817
397,817


The notes on pages 22 to 44 form part of these financial statements.

Page 16

 
KONKU CARE (SUTTON) LIMITED
 

COMPANY STATEMENT OF CHANGES IN EQUITY
FOR THE PERIOD ENDED 31 DECEMBER 2025


Called up share capital
Profit and loss account
Total equity

£
£
£

At 1 January 2025
100
502
602


Comprehensive income for the period

Loss for the period

-
(29,530)
(29,530)


Other comprehensive income for the period
-
-
-


Total comprehensive income for the period
-
(29,530)
(29,530)


Total transactions with owners
-
-
-


At 31 December 2025
100
(29,028)
(28,928)


The notes on pages 22 to 44 form part of these financial statements.

Page 17

 
KONKU CARE (SUTTON) LIMITED
 

COMPANY STATEMENT OF CHANGES IN EQUITY
FOR THE PERIOD ENDED 31 DECEMBER 2024


Called up share capital
Profit and loss account
Total equity

£
£
£


Comprehensive income for the period

Profit for the period

-
502
502


Other comprehensive income for the period
-
-
-


Total comprehensive income for the period
-
502
502


Contributions by and distributions to owners

Shares issued during the period
100
-
100


Total transactions with owners
100
-
100


At 31 December 2024
100
502
602


The notes on pages 22 to 44 form part of these financial statements.

Page 18

 
KONKU CARE (SUTTON) LIMITED
 

CONSOLIDATED STATEMENT OF CASH FLOWS
FOR THE PERIOD ENDED 31 DECEMBER 2025

2025
2024
£
£

Cash flows from operating activities

Profit for the financial period
298,284
146,542

Adjustments for:

Amortisation of intangible assets
232,432
115,249

Depreciation of tangible assets
142,286
12,820

Loss on disposal of tangible assets
350
-

Interest paid
357,469
143,978

Interest received
(51,482)
(14)

Taxation charge
191,635
183,672

(Increase) in debtors
(514,187)
(340,284)

(Increase)/decrease in amounts owed by groups
(2,695,051)
-

Increase in creditors
440,689
373,437

Increase in amounts owed to groups
400,197
3,586,818

Increase in tax provisions
196,244
-

Corporation tax (paid)
(112,609)
(111)

Net cash generated from operating activities

(1,113,743)
4,222,107


Cash flows from investing activities

Purchase of intangible fixed assets
(3,780,779)
(1,536,652)

Purchase of tangible fixed assets
(5,320,954)
(4,879,976)

Sale of tangible fixed assets
230
-

Interest received
51,482
14

Net cash from investing activities

(9,050,021)
(6,416,614)

Cash flows from financing activities

Issue of ordinary shares
-
100

New secured loans
13,505,550
2,513,840

Repayment of loans
(2,568,833)
-

Interest paid
(357,469)
(143,978)

Net cash used in financing activities
10,579,248
2,369,962

Net increase in cash and cash equivalents
415,484
175,455

Cash and cash equivalents at beginning of period
175,455
-

Cash and cash equivalents at the end of period
590,939
175,455


Cash and cash equivalents at the end of period comprise:
Page 19

 
KONKU CARE (SUTTON) LIMITED
 

CONSOLIDATED STATEMENT OF CASH FLOWS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2025


2025
2024

£
£


Cash at bank and in hand
590,939
175,455

590,939
175,455


The notes on pages 22 to 44 form part of these financial statements.

Page 20

 
KONKU CARE (SUTTON) LIMITED
 

CONSOLIDATED ANALYSIS OF NET DEBT
FOR THE PERIOD ENDED 31 DECEMBER 2025





At 1 January 2025
Cash flows
Acquisition and disposal of subsidiaries
At 31 December 2025
£

£

£

£

Cash at bank and in hand

175,455

415,484

-

590,939

Debt due after 1 year

(2,403,906)

79,659

(10,757,497)

(13,081,744)

Debt due within 1 year

(109,934)

(267,055)

-

(376,989)


(2,338,385)
228,088
(10,757,497)
(12,867,794)

The notes on pages 22 to 44 form part of these financial statements.

Page 21

 
KONKU CARE (SUTTON) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2025

1.Accounting policies

 
1.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires Group management to exercise judgment in applying the Group's accounting policies (see note 3).

The Company has taken advantage of the exemption allowed under section 408 of the Companies Act 2006 and has not presented its own Statement of comprehensive income in these financial statements.

The following principal accounting policies have been applied:

 
1.2

Basis of consolidation

The consolidated financial statements present the results of the Company and its own subsidiaries ("the Group") as if they form a single entity. Intercompany transactions and balances between group companies are therefore eliminated in full.

The consolidated financial statements incorporate the results of business combinations using the purchase method. In the Balance sheet, the acquiree's identifiable assets, liabilities and contingent liabilities are initially recognised at their fair values at the acquisition date. The results of acquired operations are included in the Consolidated statement of comprehensive income from the date on which control is obtained. They are deconsolidated from the date control ceases.

In accordance with the transitional exemption available in FRS 102, the Group has chosen not to retrospectively apply the standard to business combinations that occurred before the date of transition to FRS 102, being 03 October 2023.

Page 22

 
KONKU CARE (SUTTON) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2025

1.Accounting policies (continued)

 
1.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Group and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Sale of goods

Revenue from the sale of goods is recognised when all of the following conditions are satisfied:
∙the Group has transferred the significant risks and rewards of ownership to the buyer;
∙the Group retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
∙the amount of revenue can be measured reliably;
∙it is probable that the Group will receive the consideration due under the transaction; and
∙the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
∙the amount of revenue can be measured reliably;
∙it is probable that the Group will receive the consideration due under the contract;
∙the stage of completion of the contract at the end of the reporting period can be measured reliably; and
∙the costs incurred and the costs to complete the contract can be measured reliably.

 
1.4

Operating leases: the Group as lessee

Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the lease term.

Benefits received and receivable as an incentive to sign an operating lease are recognised on a straight-line basis over the lease term, unless another systematic basis is representative of the time pattern of the lessee's benefit from the use of the leased asset.

 
1.5

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
1.6

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

Page 23

 
KONKU CARE (SUTTON) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2025

1.Accounting policies (continued)

 
1.7

Borrowing costs

All borrowing costs are recognised in profit or loss in the period in which they are incurred.

 
1.8

Pensions

Defined contribution pension plan

The Group operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Group pays fixed contributions into a separate entity. Once the contributions have been paid the Group has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance sheet. The assets of the plan are held separately from the Group in independently administered funds.

 
1.9

Current and deferred taxation

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company and the Group operate and generate income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
∙The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits;
∙Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met; and
∙Where they relate to timing differences in respect of interests in subsidiaries, associates, branches and joint ventures and the Group can control the reversal of the timing differences and such reversal is not considered probable in the foreseeable future.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Page 24

 
KONKU CARE (SUTTON) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2025

1.Accounting policies (continued)

 
1.10

Intangible assets

Goodwill

Goodwill represents the difference between amounts paid on the cost of a business combination and the acquirer’s interest in the fair value of the Group's share of its identifiable assets and liabilities of the acquiree at the date of acquisition. Subsequent to initial recognition, goodwill is measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is amortised on a straight-line basis to the Consolidated statement of comprehensive income over its useful economic life.

Other intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

 The estimated useful lives range as follows:

Goodwill
-
10
years

 
1.11

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, as set out below.

Depreciation is provided on the following basis:

Freehold property
-
based on fair value and 2% charge on buildings
Plant and machinery
-
Motor vehicles
-
25%
Reducing balance basis
Fixtures and fittings
-
25%
Straight line basis
Office equipment
-
25%
Straight line basis
Computer equipment
-
33%
Straight line basis

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

Page 25

 
KONKU CARE (SUTTON) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2025

1.Accounting policies (continued)

 
1.12

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.

 
1.13

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
1.14

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

In the Consolidated statement of cash flows, cash and cash equivalents are shown net of bank overdrafts that are repayable on demand and form an integral part of the Group's cash management.

 
1.15

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
1.16

Provisions for liabilities

Provisions are recognised when an event has taken place that gives rise to a legal or constructive obligation, a transfer of economic benefits is probable and a reliable estimate can be made.

Provisions are measured as the best estimate of the amount required to settle the obligation, taking into account the related risks and uncertainties.
 
Increases in provisions are generally charged as an expense to profit or loss.

 
1.17

Financial instruments

The Group has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the Group's Balance sheet when the Group becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include trade and other debtors, cash and bank balances, are initially measured at their transaction price (adjusted for transaction costs except in the initial measurement of financial assets that are subsequently measured at fair value through profit and loss) and are
Page 26

 
KONKU CARE (SUTTON) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2025

1.Accounting policies (continued)


1.17
Financial instruments (continued)

subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The Group's cash and cash equivalents, trade and most other debtors due with the operating cycle fall into this category of financial instruments.

Impairment of financial assets

At the end of each reporting period financial assets measured at amortised cost are assessed for objective evidence of impairment. If an asset is impaired the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss. 

Financial assets are impaired when events, subsequent to their initial recognition, indicate the estimated future cash flows derived from the financial asset(s) have been adversely impacted. The impairment loss will be the difference between the current carrying amount and the present value of the future cash flows at the asset(s) original effective interest rate.

If there is a favourable change in relation to the events surrounding the impairment loss then the impairment can be reviewed for possible reversal. The reversal will not cause the current carrying amount to exceed the original carrying amount had the impairment not been recognised. The impairment reversal is recognised in the profit or loss.

Basic financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Group after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other creditors, bank loans, other loans and loans due to fellow group companies are initially measured at their transaction price (adjusting for transaction costs except in the initial measurement of financial liabilities that are subsequently measured at fair value through profit and loss). When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future payments discounted at a market rate of interest, discounting is omitted where the effect of discounting is immaterial.

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.

Trade creditors are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade creditors are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.

Other financial instruments

Derivatives, including forward exchange contracts, futures contracts and interest rate swaps, are not classified as basic financial instruments. These are initially recognised at fair value on the date the
Page 27

 
KONKU CARE (SUTTON) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2025

1.Accounting policies (continued)


1.17
Financial instruments (continued)

derivative contract is entered into, with costs being charged to the profit or loss. They are subsequently measured at fair value with changes in the profit or loss.

Debt instruments that do not meet the conditions as set out in FRS 102 paragraph 11.9 are subsequently measured at fair value through the profit or loss. This recognition and measurement would also apply to financial instruments where the performance is evaluated on a fair value basis as with a documented risk management or investment strategy.

Derecognition of financial instruments

Derecognition of financial assets

Financial assets are derecognised when their contractual right to future cash flow expire, or are settled, or when the Group transfers the asset and substantially all the risks and rewards of ownership to another party. If significant risks and rewards of ownership are retained after the transfer to another party, then the Group will continue to recognise the value of the portion of the risks and rewards retained.

Derecognition of financial liabilities

Financial liabilities are derecognised when the Group's contractual obligations expire or are discharged or cancelled.


2.


General information

The company is a private limited company incorporated in England and Wales. Its registered office is situated at Orchard House, 35 Hallmead Road, Sutton, Surrey SM1 1RD.


3.


Judgments in applying accounting policies and key sources of estimation uncertainty

Estimates and judgements are continually evaluated and are based on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. The resulting accounting estimates will therefore seldom equal the related actual results.

The significant estimates and assumptions are detailed below:-

Revenue Recognition

Revenue recoginition is based on the charges for bed spaces relating to the period in which the bed is occupied. 

Page 28

 
KONKU CARE (SUTTON) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2025

4.


Turnover

An analysis of turnover by class of business is as follows:


31 December
Period ended
31 December
2025
2024
£
£

Resident occupancy fees
715,185
510,883

NHS occupancy fees
3,222,804
2,118,341

RNCC fees
441,313
292,350

Other fees
768,644
270,524

5,147,946
3,192,098


Analysis of turnover by country of destination:

31 December
Period ended
31 December
2025
2024
£
£

United Kingdom
5,147,946
3,192,098

5,147,946
3,192,098



5.


Other operating income

31 December
Period ended
31 December
2025
2024
£
£

Net rents receivable
7,872
-

Commissions receivable
2,481
-

10,353
-


Page 29

 
KONKU CARE (SUTTON) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2025

6.


Operating profit

The operating profit is stated after charging:

31 December
Period ended
31 December
2025
2024
£
£

Other operating lease rentals
940
-


7.


Auditors' remuneration

During the period, the Group obtained the following services from the Company's auditors:


31 December
Period ended
31 December
2025
2024
£
£

Fees payable to the Company's auditors for the audit of the consolidated and Parent Company's financial statements
14,400
14,400

Page 30

 
KONKU CARE (SUTTON) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2025

8.


Employees

Staff costs, including director's remuneration, were as follows:


Group
Group
Company
Company
2025
2024
2025
2024
£
£
£
£


Wages and salaries
2,895,673
1,822,373
2,154
-

Social security costs
330,034
161,226
-
-

Cost of defined contribution scheme
58,956
233,557
-
-

3,284,663
2,217,156
2,154
-


The average monthly number of employees, including the director, during the period was as follows:


     31 December
     Period ended
      31 December
        2025
        2024
            No.
            No.







S J Pittman Limited
36
37



Sutton Nursing Homes Limited
44
43



Churchill Residential Care and Nursing Homes Limited
46
-

126
80


9.


Director's remuneration

31 December
Period ended
31 December
2025
2024
£
£

Director's emoluments
2,154
-

2,154
-


Page 31

 
KONKU CARE (SUTTON) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2025

10.


Interest receivable

31 December
Period ended
31 December
2025
2024
£
£


Other interest receivable
51,482
14

51,482
14


11.


Interest payable and similar expenses

31 December
Period ended
31 December
2025
2024
£
£


Bank interest payable
355,436
143,978

Other interest payable
2,033
-

357,469
143,978

Page 32

 
KONKU CARE (SUTTON) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2025

12.


Taxation


31 December
Period ended
31 December
2025
2024
£
£

Corporation tax


Current tax on profits for the year
206,617
112,720


206,617
112,720


Total current tax
206,617
112,720

Deferred tax


Origination and reversal of timing differences
(14,982)
70,952

Total deferred tax
(14,982)
70,952


Tax on profit
191,635
183,672
Page 33

 
KONKU CARE (SUTTON) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2025
 
12.Taxation (continued)


Factors affecting tax charge for the period

The tax assessed for the period is higher than (2024 - higher than) the standard rate of corporation tax in the UK of 25% (2024 - 25%). The differences are explained below:

31 December
Period ended
31 December
2025
2024
£
£


Profit on ordinary activities before tax
489,919
330,214


Profit on ordinary activities multiplied by standard rate of corporation tax in the UK of 25% (2024 - 25%)
122,480
82,554

Effects of:


Non-tax deductible amortisation of goodwill and impairment
58,108
28,813

Expenses not deductible for tax purposes, other than goodwill amortisation and impairment
25,999
-

Capital allowances for period in excess of depreciation
(7,353)
1,353

Short-term timing difference leading to an increase (decrease) in taxation
(7,599)
70,952

Total tax charge for the period
191,635
183,672


Factors that may affect future tax charges

There were no factors that may affect future tax charges.

Page 34

 
KONKU CARE (SUTTON) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2025

13.


Intangible assets

Group and Company





Goodwill

£





At 1 January 2025
1,536,653


Additions
3,780,779



At 31 December 2025

5,317,432





At 1 January 2025
115,249


Charge for the period on owned assets
232,432



At 31 December 2025

347,681



Net book value



At 31 December 2025
4,969,751



At 31 December 2024
1,421,404


Page 35

 
KONKU CARE (SUTTON) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2025

14.


Tangible fixed assets

Group



Freehold property
Plant and machinery
Motor vehicles
Fixtures and fittings
Office equipment
Computer equipment

£
£
£
£
£
£



Cost or valuation


At 1 January 2025
5,060,000
-
714
44,147
20,353
5,937


Additions
5,120,000
132,717
24,199
24,543
11,152
8,343


Disposals
-
-
(714)
-
-
-



At 31 December 2025

10,180,000
132,717
24,199
68,690
31,505
14,280



Depreciation


At 1 January 2025
-
-
134
6,622
3,817
2,248


Charge for the period on owned assets
98,204
1,686
3,168
20,084
14,550
4,594


Disposals
-
-
(134)
-
-
-



At 31 December 2025

98,204
1,686
3,168
26,706
18,367
6,842



Net book value



At 31 December 2025
10,081,796
131,031
21,031
41,984
13,138
7,438



At 31 December 2024
5,060,000
-
580
37,525
16,536
3,689
Page 36

 
KONKU CARE (SUTTON) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2025

           14.Tangible fixed assets (continued)


Total

£



Cost or valuation


At 1 January 2025
5,131,151


Additions
5,320,954


Disposals
(714)



At 31 December 2025

10,451,391



Depreciation


At 1 January 2025
12,821


Charge for the period on owned assets
142,286


Disposals
(134)



At 31 December 2025

154,973



Net book value



At 31 December 2025
10,296,418



At 31 December 2024
5,118,330




The net book value of land and buildings may be further analysed as follows:


2025
2024
£
£

Freehold property
10,081,796
5,060,000

10,081,796
5,060,000


Page 37

 
KONKU CARE (SUTTON) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2025

15.


Fixed asset investments

Company





Investments in subsidiary companies

£



Cost or valuation


At 1 January 2025
4,225,000


Additions
8,598,617



At 31 December 2025
12,823,617





Direct subsidiary undertaking


The following was a direct subsidiary undertaking of the Company:

Name

Registered office

Class of shares

Holding

Pittman (Holdings) Limited
Orchard House, 35 Hallmead Road, Sutton SM1 1RD
Ordinary
100%

Page 38

 
KONKU CARE (SUTTON) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2025

Indirect subsidiary undertakings


The following were indirect subsidiary undertakings of the Company:

Name

Registered office

Class of shares

Holding

LNH Properties Limited
Orchard House, 35 Hallmead Road, Sutton SM1 1RD
Ordinary
100%
SNH Properties Limited
Orchard House, 35 Hallmead Road, Sutton SM1 1RD
Ordinary
100%
S J Pittman Limited
Orchard House, 35 Hallmead Road, Sutton SM1 1RD
Ordinary
100%
Sutton Nursing Homes Limited
Orchard House, 35 Hallmead Road, Sutton SM1 1RD
Ordinary
100%
Churchill Investments (UK) Limited
Orchard House, 35 Hallmead Road, Sutton SM1 1RD
Ordinary
100%
Churchill Residential Care and Nursing Homes Limited
Orchard House, 35 Hallmead Road, Sutton SM1 1RD
Ordinary
100%


16.


Debtors

Group
Group
Company
Company
2025
2024
2025
2024
£
£
£
£


Trade debtors
489,325
271,971
-
-

Amounts owed by group undertakings
2,695,051
-
4,821,071
2,376,769

Other debtors
300,000
-
300,000
-

Prepayments and accrued income
65,148
68,315
-
-

3,549,524
340,286
5,121,071
2,376,769




17.


Cash and cash equivalents

Group
Group
Company
Company
2025
2024
2025
2024
£
£
£
£

Cash at bank and in hand
590,939
175,455
3,599
10,375

590,939
175,455
3,599
10,375


Page 39

 
KONKU CARE (SUTTON) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2025

18.


Creditors: Amounts falling due within one year

Group
Group
Company
Company
2025
2024
2025
2024
£
£
£
£

Bank loans
368,813
109,934
368,813
109,934

Trade creditors
86,769
98,291
-
-

Amounts owed to group undertakings
3,987,015
3,586,818
4,526,324
4,097,535

Corporation tax
222,845
112,609
-
167

Other taxation and social security
212,686
56,624
-
-

Other creditors
403,937
177,247
334
-

Accruals and deferred income
110,736
41,276
-
-

5,392,801
4,182,799
4,895,471
4,207,636



The following liabilities were secured:
Group
Group
Company
Company
2025
2024
2025
2024
£
£
£
£

Bank loans
368,813
109,934
368,813
109,934

368,813
109,934
368,813
109,934

Details of security provided:

The bank loans are secured on the group's and wider group's freehold properties as well as by a fixed and floating charge.over all the assets of the group and wider group companies.

Page 40

 
KONKU CARE (SUTTON) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2025

19.


Creditors: Amounts falling due after more than one year

Group
Group
Company
Company
2025
2024
2025
2024
£
£
£
£

Bank loans
13,081,744
2,403,906
13,081,744
2,403,906

13,081,744
2,403,906
13,081,744
2,403,906



The following liabilities were secured:
Group
Group
Company
Company
2025
2024
2025
2024
£
£
£
£


Bank loans
13,081,744
2,403,906
13,081,744
2,403,906

13,081,744
2,403,906
13,081,744
2,403,906

Details of security provided:

The bank loans are secured on the group's and wider group's freehold properties as well as by a fixed and floating charge.over all the assets of the group and wider group companies.


The aggregate amount of liabilities repayable wholly or in part more than five years after the balance sheet date is:
Group
Group
Company
Company
2025
2024
2025
2024
£
£
£
£


Repayable by instalments
10,873,940
2,403,906
10,873,940
2,403,906

10,873,940
2,403,906
10,873,940
2,403,906



Page 41

 
KONKU CARE (SUTTON) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2025

20.


Loans


Analysis of the maturity of loans is given below:


Group
Group
Company
Company
2025
2024
2025
2024
£
£
£
£

Amounts falling due within one year

Bank loans
368,813
109,934
368,813
109,934


368,813
109,934
368,813
109,934

Amounts falling due 1-2 years

Bank loans
391,171
114,098
391,171
114,098


391,171
114,098
391,171
114,098

Amounts falling due 2-5 years

Bank loans
1,816,633
404,486
1,816,633
404,486


1,816,633
404,486
1,816,633
404,486

Amounts falling due after more than 5 years

Bank loans
10,873,940
1,885,322
10,873,940
1,885,322

10,873,940
1,885,322
10,873,940
1,885,322

13,450,557
2,513,840
13,450,557
2,513,840



21.


Deferred taxation


Group



2025


£






At beginning of year
(70,952)


Charged to profit or loss
(165,034)



At end of year
(235,986)

Page 42

 
KONKU CARE (SUTTON) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2025
 
21.Deferred taxation (continued)

Company


2025






At end of year
-
The provision for deferred taxation is made up as follows:

Group
Group
2025
2024
£
£

Accelerated capital allowances
(7,440)
(8,158)

Tax losses carried forward
7,382
-

Tax provision on revaluation of properties
(235,928)
(62,794)

(235,986)
(70,952)


22.


Share capital

2025
2024
£
£
Allotted, called up and fully paid



100 (2024 - 100) Ordinary shares of £1.00 each
100
100



23.


Contingent liabilities

There is a fixed and floating charge over all the assets of the company by Barclays Bank Plc. The charge includes a cross guarantee between all the members of the wider group. The amount outstanding to Barclays Bank Plc by that group at the balance sheet date amounted to £13,450,557 (2024 - £4,715,819).


24.


Pension commitments

The Group operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the Group  in an independently administered fund. The pension cost charge represents contributions payable by the Group  to the fund and amounted to £58,956 (2024 - £233,557). Contributions totalling £9,956 (2024 - £8,867) were payable to the fund at the balance sheet date and are included in creditors.

Page 43

 
KONKU CARE (SUTTON) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2025

25.


Related party transactions

Included in creditors falling due within one year is the amount of £3,947,015 (2024 - £3,586,818) due to the parent company, Konku Holdings Limited, a company in which the director has a material interest.

Included in interest receivable is the sum of £46,250 (2024 - £Nil) from Konku Care Limited, a company which is another subsidiary of Konku Holdings Limited.


26.


Controlling party

The company and group are controlled by S K Konkumalla and B Konkumalla.

 
Page 44